- CSR Summary Not Available
- NCT03464136
- Primary Citation
- Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameUstekinumabProduct NameSTELARA®Therapeutic AreaImmune System DiseasesEnrollment386% Female52.1%% White89.4%
Product ClassAntirheumatic Agents - Biologic Response ModifiersSponsor Protocol NumberCNTO1275CRD3007Data PartnerJohnson & JohnsonCondition StudiedCrohn's DiseaseMean/Median Age (Years)37.2
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available